11/11/2025
The latest episode of the Molecular Therapy podcast is out now!
This in-depth conversation between Dr. Joseph Glorioso, Editor-in-Chief of Molecular Therapy, Dr. Rachael Nimmo, former director of the Cell Technology Group at OXB, and Dr. Kyriacos Mitrophanous, Chief Innovation Officer at OXB, focuses on an article recently published in Molecular Therapy titled “Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector.”
🎙️ Listen:
Editor-in-Chief of Molecular Therapy, Dr. Joseph Glorioso, is joined by Rachael Nimmo, PhD, and Kyriacos Mitrophanous, PhD, to discuss “Efficient in vivo…